Suppr超能文献

养老院 2 型糖尿病患者血糖治疗减量化实践。

Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes.

机构信息

Geriatrics and Extended Care Service, San Francisco Virginia Medical Center, San Francisco, California, USA.

Veterans Affairs Quality Scholars Fellowship, San Francisco Virginia Medical Center, San Francisco, California, USA.

出版信息

J Am Geriatr Soc. 2022 Jul;70(7):2019-2028. doi: 10.1111/jgs.17735. Epub 2022 Mar 23.

Abstract

BACKGROUND

Older nursing home (NH) residents with glycemic overtreatment are at significant risk of hypoglycemia and other harms and may benefit from deintensification. However, little is known about deintensification practices in this setting.

METHODS

We conducted a cohort study from January 1, 2013 to December 31, 2019 among Veterans Affairs (VA) NH residents. Participants were VA NH residents age ≥65 with type 2 diabetes with a NH length of stay (LOS) ≥ 30 days and an HbA1c result during their NH stay. We defined overtreatment as HbA1c <6.5 with any insulin use, and potential overtreatment as HbA1c <7.5 with any insulin use or HbA1c <6.5 on any glucose-lowering medication (GLM) other than metformin alone. Our primary outcome was continued glycemic overtreatment without deintensification 14 days after HbA1c.

RESULTS

Of the 7422 included residents, 17% of residents met criteria for overtreatment and an additional 23% met criteria for potential overtreatment. Among residents overtreated and potentially overtreated at baseline, 27% and 19%, respectively had medication regimens deintensified (73% and 81%, respectively, continued to be overtreated). Long-acting insulin use and hyperglycemia ≥300 mg/dL before index HbA1c were associated with increased odds of continued overtreatment (odds ratio [OR] 1.37, 95% confidence interval [CI] 1.14-1.65 and OR 1.35, 95% CI 1.10-1.66, respectively). Severe functional impairment (MDS-ADL score ≥ 19) was associated with decreased odds of continued overtreatment (OR 0.72, 95% CI 0.56-0.95). Hypoglycemia was not associated with decreased odds of overtreatment.

CONCLUSIONS

Overtreatment of diabetes in NH residents is common and a minority of residents have their medication regimens appropriately deintensified. Deprescribing initiatives targeting residents at high risk of harms and with low likelihood of benefit such as those with history of hypoglycemia, or high levels of cognitive or functional impairment are most likely to identify NH residents most likely to benefit from deintensification.

摘要

背景

血糖过度治疗的老年疗养院(NH)居民有发生低血糖和其他危害的重大风险,可能受益于降糖方案的调整。然而,关于这种环境下降糖方案调整的实践知之甚少。

方法

我们进行了一项队列研究,纳入了 2013 年 1 月 1 日至 2019 年 12 月 31 日期间 VA NH 居民。参与者为 VA NH 居民,年龄≥65 岁,患有 2 型糖尿病,NH 入住时间≥30 天,NH 期间有 HbA1c 结果。我们将 HbA1c<6.5 且使用任何胰岛素定义为过度治疗,将 HbA1c<7.5 且使用任何胰岛素或 HbA1c<6.5 且使用除二甲双胍以外的任何降糖药物(GLM)定义为潜在过度治疗。我们的主要结局是在 HbA1c 后 14 天继续发生无降糖方案调整的血糖过度治疗。

结果

在纳入的 7422 名居民中,17%的居民符合过度治疗标准,另有 23%的居民符合潜在过度治疗标准。在基线时过度治疗和潜在过度治疗的居民中,分别有 27%和 19%的居民调整了药物治疗方案(分别有 73%和 81%的居民继续过度治疗)。在调整方案的居民中,HbA1c 之前有长时胰岛素使用和高血糖(≥300mg/dL)与持续过度治疗的可能性增加相关(比值比 [OR] 1.37,95%置信区间 [CI] 1.14-1.65 和 OR 1.35,95% CI 1.10-1.66)。严重的功能障碍(MDS-ADL 评分≥19)与持续过度治疗的可能性降低相关(OR 0.72,95% CI 0.56-0.95)。低血糖与降低过度治疗的可能性无关。

结论

NH 居民糖尿病的过度治疗很常见,只有少数居民的药物治疗方案得到了适当的调整。针对那些有低血糖史或认知或功能障碍程度较高的高风险和低获益居民的药物停减策略,最有可能确定最有可能从降糖方案调整中获益的 NH 居民。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5598/9545448/5ed535bf4b66/JGS-70-2019-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验